Maravai Soars After Reported Takeover Offer from Repligen (1)

Maravai LifeSciences Holdings Inc. shares soared after a report that the drug research and manufacturing firm received a takeover offer from Repligen Corp.

Maravai shares rose as much as 25% on Friday to $9.95 after Reuters reported the approach, raising its market valuation to about $2.6 billion from $2.08 billion. Repligen shares fell as much as 14% as of 12:50 p.m. in New York.

A deal would be the latest sign of consolidation among companies that help drugmakers develop and manufacture new treatments. Last year, Thermo Fisher Scientific Inc. agreed to acquire Olink Holding AB in a $3.1 billion deal, ...